Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children; Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Buprenorphine used in Treatment; Naltrexone used in Treatment; No formal relationship with prescribing entity; This facility administers/prescribes medication for alcohol use disorder; No formal relationship with prescribing entity; Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation; Local, county, or community government; State Substance use treatment agency; State mental health department; The Joint Commission; Medicare; Medicaid; Cash or self-payment; Payment assistance (check with facility for details); Sliding fee scale (fee is based on income and other factors); Comprehensive mental health assessment; Screening for tobacco use; Screening for substance use; Screening for mental disorders; Drug or alcohol urine screening; Metabolic syndrome monitoring; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV); Discharge Planning; Naloxone and overdose education; Assistance with obtaining social services; Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling; Smoking not permitted; Adults; Young adults; Female; Male; Vaping not permitted; Case management service; Mental health services; Suicide prevention services